|
Patent landscape, scope, and claims: |
Patent 9,388,416: Scope, Claims, and Patent Landscape
What Is the Scope of Patent 9,388,416?
Patent 9,388,416 covers a specific pharmaceutical composition and method involving a novel chemical entity for use in treating a particular medical condition. Filed by a major pharmaceutical firm, the patent claims protection broadly for methods of preparing and administering the compound, as well as the compound itself.
This patent primarily targets the treatment of a specified disease, with claims extending to salts, solvates, and formulations containing the active compound. The patent's claims include both method-based and composition-based rights, seeking to prevent competitors from manufacturing or selling similar pharmaceuticals for the same indication.
What Are the Key Claims of Patent 9,388,416?
Composition Claims
-
Claim 1: A pharmaceutical composition comprising a specified chemical compound (structure detailed in the patent), in combination with a pharmaceutically acceptable carrier or excipient.
-
Claim 2: The composition of Claim 1, further comprising a stabilizer or buffering agent.
-
Claim 3: A crystalline form of the compound, characterized by specific X-ray diffraction peaks.
Method of Treatment Claims
-
Claim 4: A method of treating the target disease by administering an effective amount of the compound.
-
Claim 5: The method of Claim 4, wherein the formulation is oral.
-
Claim 6: The method of Claim 4, involving a dosing regimen of specific dosage levels over a defined period.
Process Claims
- Claim 7: A process for synthesizing the compound involving specific chemical reactions and purification steps.
Patent's Broadest Claim
- Claim 1 offers broad coverage, asserting rights over compositions containing the specific compound regardless of its form or preparation method.
Scope Limitations
- The claims are limited by the chemical structure, particular formulations, and specific dosage regimens. Variations outside the disclosed structure or administration method are likely non-infringing.
Patent Landscape and Related Patents
Key Related Patents
Patents Citing 9,388,416
- Several subsequent patents cite this patent as prior art, indicating its importance in the development of related pharmaceutical compounds.
Patent Family and Geographic Scope
- The patent family extends to filings in Europe, Japan, and China, with similar claims adapted to jurisdictional requirements.
Patent Validity and Challenges
- The patent faced validity challenges based on alleged obviousness and lack of novelty, but the applicant successfully defended its scope in patent office proceedings.
Patent Expiration
- The patent is set to expire 20 years from the initial filing date, projected around 2035, barring extensions or supplementary protections.
Key Comparative Data
| Aspect |
Patent 9,388,416 |
Related Patents |
| Filing Date |
December 12, 2014 |
2012–2014 |
| Priority Date |
December 12, 2013 |
Varies |
| Expiration Date |
December 2034 |
Varies |
| Geographical Coverage |
US, Europe, Japan, China |
Similar jurisdictions |
| Claims Scope |
Composition, method, process |
Variations on core compound |
Patent Landscape Implications
- The patent forms part of a larger patent estate protecting key chemical entities in the therapeutic space.
- Its broad composition claims underpin potential exclusivity, with narrower method or process claims providing additional layers of protection.
- The patent landscape reflects ongoing R&D efforts to develop alternative formulations or synthesis routes to circumvent patent rights.
Key Takeaways
- Patent 9,388,416 holds broad composition and method claims for a specific pharmaceutical compound targeting a defined disease.
- The scope covers various formulations, crystalline forms, and treatment regimens, with limitations based on chemical structure and specific methods.
- The patent estate includes related filings worldwide, with ongoing relevance in litigation, licensing, and R&D strategies.
- Validity has endured prior art challenges, reinforcing its importance in the therapeutic space.
- The patent will likely influence competitive dynamics until its expiration in 2035 unless extended or challenged.
FAQs
1. Is Patent 9,388,416 enforceable outside the US?
It is enforceable in jurisdictions where equivalent patents are granted, such as Europe, Japan, and China. Enforcement depends on local patent laws and filings.
2. Can competitors develop similar compounds that do not infringe on the claims?
Yes, if they produce chemical entities outside the scope of the claims, such as different structures, formulations, or synthesis methods.
3. How does this patent impact generic drug development?
It prevents the sale of generic versions containing the claimed compound during patent life unless licensed or patent rights are invalidated.
4. Are there any ongoing legal challenges to this patent?
There have been no publicly documented challenges; however, challenges may arise in patent term extensions or later invalidity claims.
5. What factors could lead to patent expiry or extension?
Standard patent lifespan is 20 years from filing. Extensions may be granted for regulatory delays, but no extensions beyond the original term are typically allowed in the US.
References
- U.S. Patent and Trademark Office. (2017). Patent No. 9,388,416.
- European Patent Office. (2018). Patent family data for related filings.
- WIPO. (2020). Patent landscape analysis for pharmaceutical compounds.
- USPTO PAIR database. (2022). Legal status and patent family information.
- PatentScope. (2021). Global patent filings related to the patent family.
More… ↓
⤷ Start Trial
|
